Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide

Katalin A. Wilkinson, F. Hudecz, H. Martin Vordermeier, Juraj Ivanyi, Robert J.wilkinson

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A peptide-based approach towards improving the immunodiagnosis of, and vaccination against, tuberculosis faces the problems of MHC restriction of T cell recognition and the poor immunogenicity of peptides in the absence of adjuvant. We sought to compensate this by the use of synthetic branched polypeptides of the poly[Lys-(X(i)-DL-Ala(m))] type, containing a glutamic acid residue (EAK), and further modified either by succinylation (SucEAK) or acetylation (AcEAK). These carriers were conjugated to two permissively recognized peptides of Mycobacterium tuberculosis. The 38p350-369-SucEAK conjugate enhanced IFN-γ production more than 13-fold (from 22.6 to 294 pg/ml, p = 0.001) in peripheral blood mononuclear cells from healthy subjects, and 8.7-fold (p = 0.012) in cells from tuberculosis patients. The effect was dependent on the carrier used and on covalent linkage of SucEAK to 38p350-369. An increased response occurred best in cells from subjects bearing at least one HLA-DR allele for which 38p350-369 had high binding affinity and required cellular processing of the conjugate as inhibitors (chloroquine and wortmannin) blocked the IFN-γ response. SucEAK conjugation of peptide 16p91-110 did not significantly increase IFN-γ production, indicating that the ability of conjugation to enhance the response was peptide structure dependent. These data indicate that the use of SucEAK polymer coupled with permissively recognized peptides could contribute to the development of an improved immunodiagnostic or vaccine reagent for tuberculosis.

Original languageEnglish
Pages (from-to)2788-2796
Number of pages9
JournalEuropean Journal of Immunology
Volume29
Issue number9
Publication statusPublished - 1999

Fingerprint

T-Lymphocytes
Peptides
Tuberculosis
Tuberculosis Vaccines
Immunologic Tests
Chloroquine
HLA-DR Antigens
Acetylation
Mycobacterium tuberculosis
Glutamic Acid
Blood Cells
Healthy Volunteers
Polymers
Vaccination
Alleles

Keywords

  • α-crystallin
  • 38-kDa antigen
  • Epitope
  • Peptide
  • T lymphocyte
  • Tuberculosis

ASJC Scopus subject areas

  • Immunology

Cite this

Wilkinson, K. A., Hudecz, F., Martin Vordermeier, H., Ivanyi, J., & J.wilkinson, R. (1999). Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide. European Journal of Immunology, 29(9), 2788-2796.

Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide. / Wilkinson, Katalin A.; Hudecz, F.; Martin Vordermeier, H.; Ivanyi, Juraj; J.wilkinson, Robert.

In: European Journal of Immunology, Vol. 29, No. 9, 1999, p. 2788-2796.

Research output: Contribution to journalArticle

Wilkinson, KA, Hudecz, F, Martin Vordermeier, H, Ivanyi, J & J.wilkinson, R 1999, 'Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide', European Journal of Immunology, vol. 29, no. 9, pp. 2788-2796.
Wilkinson, Katalin A. ; Hudecz, F. ; Martin Vordermeier, H. ; Ivanyi, Juraj ; J.wilkinson, Robert. / Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide. In: European Journal of Immunology. 1999 ; Vol. 29, No. 9. pp. 2788-2796.
@article{300b918019a34073b4f4f0e2a195bd5a,
title = "Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide",
abstract = "A peptide-based approach towards improving the immunodiagnosis of, and vaccination against, tuberculosis faces the problems of MHC restriction of T cell recognition and the poor immunogenicity of peptides in the absence of adjuvant. We sought to compensate this by the use of synthetic branched polypeptides of the poly[Lys-(X(i)-DL-Ala(m))] type, containing a glutamic acid residue (EAK), and further modified either by succinylation (SucEAK) or acetylation (AcEAK). These carriers were conjugated to two permissively recognized peptides of Mycobacterium tuberculosis. The 38p350-369-SucEAK conjugate enhanced IFN-γ production more than 13-fold (from 22.6 to 294 pg/ml, p = 0.001) in peripheral blood mononuclear cells from healthy subjects, and 8.7-fold (p = 0.012) in cells from tuberculosis patients. The effect was dependent on the carrier used and on covalent linkage of SucEAK to 38p350-369. An increased response occurred best in cells from subjects bearing at least one HLA-DR allele for which 38p350-369 had high binding affinity and required cellular processing of the conjugate as inhibitors (chloroquine and wortmannin) blocked the IFN-γ response. SucEAK conjugation of peptide 16p91-110 did not significantly increase IFN-γ production, indicating that the ability of conjugation to enhance the response was peptide structure dependent. These data indicate that the use of SucEAK polymer coupled with permissively recognized peptides could contribute to the development of an improved immunodiagnostic or vaccine reagent for tuberculosis.",
keywords = "α-crystallin, 38-kDa antigen, Epitope, Peptide, T lymphocyte, Tuberculosis",
author = "Wilkinson, {Katalin A.} and F. Hudecz and {Martin Vordermeier}, H. and Juraj Ivanyi and Robert J.wilkinson",
year = "1999",
language = "English",
volume = "29",
pages = "2788--2796",
journal = "European Journal of Immunology",
issn = "0014-2980",
publisher = "Wiley-VCH Verlag",
number = "9",

}

TY - JOUR

T1 - Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide

AU - Wilkinson, Katalin A.

AU - Hudecz, F.

AU - Martin Vordermeier, H.

AU - Ivanyi, Juraj

AU - J.wilkinson, Robert

PY - 1999

Y1 - 1999

N2 - A peptide-based approach towards improving the immunodiagnosis of, and vaccination against, tuberculosis faces the problems of MHC restriction of T cell recognition and the poor immunogenicity of peptides in the absence of adjuvant. We sought to compensate this by the use of synthetic branched polypeptides of the poly[Lys-(X(i)-DL-Ala(m))] type, containing a glutamic acid residue (EAK), and further modified either by succinylation (SucEAK) or acetylation (AcEAK). These carriers were conjugated to two permissively recognized peptides of Mycobacterium tuberculosis. The 38p350-369-SucEAK conjugate enhanced IFN-γ production more than 13-fold (from 22.6 to 294 pg/ml, p = 0.001) in peripheral blood mononuclear cells from healthy subjects, and 8.7-fold (p = 0.012) in cells from tuberculosis patients. The effect was dependent on the carrier used and on covalent linkage of SucEAK to 38p350-369. An increased response occurred best in cells from subjects bearing at least one HLA-DR allele for which 38p350-369 had high binding affinity and required cellular processing of the conjugate as inhibitors (chloroquine and wortmannin) blocked the IFN-γ response. SucEAK conjugation of peptide 16p91-110 did not significantly increase IFN-γ production, indicating that the ability of conjugation to enhance the response was peptide structure dependent. These data indicate that the use of SucEAK polymer coupled with permissively recognized peptides could contribute to the development of an improved immunodiagnostic or vaccine reagent for tuberculosis.

AB - A peptide-based approach towards improving the immunodiagnosis of, and vaccination against, tuberculosis faces the problems of MHC restriction of T cell recognition and the poor immunogenicity of peptides in the absence of adjuvant. We sought to compensate this by the use of synthetic branched polypeptides of the poly[Lys-(X(i)-DL-Ala(m))] type, containing a glutamic acid residue (EAK), and further modified either by succinylation (SucEAK) or acetylation (AcEAK). These carriers were conjugated to two permissively recognized peptides of Mycobacterium tuberculosis. The 38p350-369-SucEAK conjugate enhanced IFN-γ production more than 13-fold (from 22.6 to 294 pg/ml, p = 0.001) in peripheral blood mononuclear cells from healthy subjects, and 8.7-fold (p = 0.012) in cells from tuberculosis patients. The effect was dependent on the carrier used and on covalent linkage of SucEAK to 38p350-369. An increased response occurred best in cells from subjects bearing at least one HLA-DR allele for which 38p350-369 had high binding affinity and required cellular processing of the conjugate as inhibitors (chloroquine and wortmannin) blocked the IFN-γ response. SucEAK conjugation of peptide 16p91-110 did not significantly increase IFN-γ production, indicating that the ability of conjugation to enhance the response was peptide structure dependent. These data indicate that the use of SucEAK polymer coupled with permissively recognized peptides could contribute to the development of an improved immunodiagnostic or vaccine reagent for tuberculosis.

KW - α-crystallin

KW - 38-kDa antigen

KW - Epitope

KW - Peptide

KW - T lymphocyte

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=0033400776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033400776&partnerID=8YFLogxK

M3 - Article

VL - 29

SP - 2788

EP - 2796

JO - European Journal of Immunology

JF - European Journal of Immunology

SN - 0014-2980

IS - 9

ER -